Chemo Research S.L. — Sponsor Intelligence | 8 EU Trials

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

2 Recruiting

6 Completed trials

14 Countries active

4 Unique IMPs

100% Results reported

Phase III

Phase IV

Phase I (Other)

Phase III: 3 Phase IV: 1 Phase I (Other): 4

100%

6 of 6 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Contraception 2 Bone density decreased 1

Top IMPs

LEVONORGESTREL 2 DESOGESTREL 1 EQUINE IMMUNOGLOBULIN F(AB')2 FRAGMENTS TARGETING SHIGA TOXIN 1

All trials

8 total

Phase 1, Randomized, Open-label, Single center study to evaluate Pharmacokinetic and Bioequivalence of Levonorgestrel Vaginal Delivery Syste… Recruiting

2025-524330-25-00 Phase I (Other) 1 country
A Phase III study to evaluate the efficacy of INM004 (Shiga antitoxin) in pediatric patients with Shiga toxin-producing Escherichia coli-ass… Recruiting

2024-512412-22-00 Phase III 8 countries EQUINE IMMUNOGLOBULIN F(AB')2 FRAGMENTS TARGETING SHIGA TOXIN
A multicenter, open-label, controlled study to investigate the effect of either LF111 or Drospirenone chewable tablets on bone mineral densi… Ended

2024-512347-23-00 Phase IV 2 countries
Phase 1 study to investigate the pharmacokinetic profile and safety of 3 testosterone gel formulations in postmenopausal female participants… Ended

2025-522726-12-00 Phase I (Other) 1 country
Investigate Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Tampons and Lubricants in Healthy Female Partic… Ended

2025-520517-32-00 Phase I (Other) 1 country
Investigation of Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Miconazole in Healthy Female Participants. Ended

2025-520516-33-00 Phase I (Other) 1 country
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 1… Ended

2022-502023-21-00 Phase III 8 countries LEVONORGESTREL
A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgest… Ended

2022-502024-51-00 Phase III 8 countries DESOGESTREL; LEVONORGESTREL

Showing 1–8 of 8 trials

← All sponsors A–Z